TCA
Trifecta Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.84M | Sell |
11,933
-60
| -0.5% | -$24.3K | 0.81% | 40 |
|
|
2025
Q1 | $5.97M | Sell |
11,993
-175
| -1% | -$87.1K | 1.25% | 29 |
|
|
2024
Q4 | $6.33M | Sell |
12,168
-40
| -0.3% | -$20.8K | 1.25% | 26 |
|
|
2024
Q3 | $7.55M | Buy |
12,208
+97
| +0.8% | +$60K | 1.58% | 16 |
|
|
2024
Q2 | $6.7M | Buy |
12,111
+608
| +5% | +$336K | 1.48% | 16 |
|
|
2024
Q1 | $6.69M | Buy |
11,503
+404
| +4% | +$235K | 1.63% | 17 |
|
|
2023
Q4 | $5.89M | Buy |
11,099
+185
| +2% | +$98.2K | 1.63% | 15 |
|
|
2023
Q3 | $5.52M | Buy |
10,914
+281
| +3% | +$142K | 1.78% | 14 |
|
|
2023
Q2 | $5.55M | Buy |
10,633
+365
| +4% | +$190K | 1.78% | 14 |
|
|
2023
Q1 | $5.92M | Buy |
10,268
+258
| +3% | +$149K | 2.08% | 13 |
|
|
2022
Q4 | $5.51M | Buy |
+10,010
| New | +$5.51M | 2.2% | 12 |
|